Promotional Review & Labeling

ProPharma has built the world’s leading and first, full-service organization dedicated to global Advertising, Promotional Review, & Labeling Services.

global-medical-writing-transparency-header-banner global-medical-writing-transparency-header-banner

Advertising & Promotional Review Services

ProPharma has built the world’s leading and first, full-service organization dedicated to global Advertising & Promotional Review services. Led by industry veterans and thought leaders, we help our clients develop compelling and compliant messaging in an efficient manner to grow their brands. With comprehensive promotional review capabilities – from Medical and Regulatory Review, technology solutions, marketing operations, to regulatory submission, and beyond – we take a flexible approach to meet our clients’ business objectives. Our expert team highlights include:

  • Global leader in Promotional Review Committee (PRC) support, having helped launch hundreds of brands and supported thousands of PRCs (US, EU, Asia, etc.)
  • Deep experience in pharmaceutical, biotechnology, vaccines, medical device (Class I, II, III), OTC drugs, nutritional supplements, animal health and cosmetic products
  • Collaborative professionals who launch new products (pre-approval, launch and post-approval brand support), support growing brands, and legacy products
  • Full-service, including PRC establishment and resourcing, system configuration and implementation, SOP generation, medical fact-checking, training and mentoring, PRC process assessment and improvement

End-To-End Promotional Review Services

Medical Review

  • Expert consultant team to manage day-to-day review responsibilities, without sacrificing scientific accuracy or integrity; each of our individual consultants is part of an organization of over 50 experts that provides the support and feedback that is required to meet your brand’s challenges
  • Promotional and Medical Review Committee participation (PRC/LMR/MLR)
  • Medical accuracy and evidentiary standard review (substantial evidence, competent and reliable/FTC)
  • Broad therapeutic experience

Regulatory Review

  • Experienced and collaborative regulatory professionals
  • Office of Prescription Drug Promotion (OPDP) or Advertising and Promotional Labeling Branch (APLB) product advisory comment submissions –authoring, editing, and preparation
  • Extensive Accelerated Approval (Subpart H) launch experience
  • Successful interactions with regulatory authorities
  • Guide teams through regulations, guidance documents and enforcement communications
  • Deep understanding of trial design and outcomes

Marketing Operations

  • Commercial Operations Infrastructure Build & Support (Policy, Process, and Procedure Development)
  • Promotional Material, Medical, Legal, Regulatory (MLR/PRC) Review Process Management (PRC Coordinator)
  • Experienced resources to maintain efficient collaboration in cross-functional teams
  • Review System implementation and configuration
  • Experience with all e-review platforms

Global Labeling

ProPharma is the leading provider of global label services for pharmaceutical, biotechnology, medical device (Class I, II, III), nutritional supplements, animal health and cosmetic products. We have unmatched expertise across regions, areas of therapy, and product types. Our team works with our clients to support and enhance their brands, whether that requires expertise in regulatory strategy, label operations, or technology. Our Global Labeling Team can support your needs in the following areas:

  • New product label strategy development and negotiations (FDA, EMA, Rest of World)
  • Lifecycle management (label expansion, global submissions)
  • Global label process establishment, assessment, and improvement
  • Target Product Profile (TPP)
  • Company Core Data Sheets (CCDS)
  • U.S. package inserts
  • Medication guides
  • Summary of Product Characteristics (SPC)
  • Patient Information Leaflets (PIL)
  • Structured Product Labeling (SPL) submission

Partner with us!

Complex Needs Require Custom Solutions

ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.

Client Feedback

"The ProPharma Group has been a valued and trusted partner as our Medical Information third party call center for a number of years. During that time they have exhibited the highest level of quality, compliance, and professionalism. Always keeping the needs of our mutual customers front and center. The team is diverse in their staff and their offered services, which enables us to customize support to business need. We would highly recommend the services of ProPharma without hesitation.”

Laurie Wingett - Bayer, Inc.

Medical Affairs Head, Primary Care (WH/established brands) and Medical Operations

“Working with Pro Pharma has been a pleasure. The auditors are friendly, knowledgeable, and communicative. They have been a great resource to help us complete a wide range of audits and
manage our supplier quality.”

Emily King - Azurity Pharmaceuticals

"Working with the whole team at ProPharma Group has been an honor. For several years they have acted on our behalf as a trusted customer facing vendor for medical information inquiries. their subject matter expertise, collaborative nature and high level of professionalism have been a bellwether for us through all stages of marketing and scaling a new drug product. The next time my team is in need of scientific communication outsourcing, PPG will be my first stop."

Jenny Strauss​ - Biohaven Pharmaceuticals

Manager, Medical Information and Communications

“Lyell engaged Pro Pharma as our validation partner as we built and qualified the LyFE Manufacturing Center. Pro Pharma assisted in all phases of the qualification including establishing the facility and equipment qualification program, protocol generation, protocol execution, and writing the final reports. They played a critical role in getting the facility ready on time and on budget to support the Lyell clinical trials.”

David Shank - Lyell Immunopharma, Inc.

Vice President, Manufacturing

When we partnered with Oxford University to enable global development, manufacturing and distribution of our vaccine, we put broad and equitable access at the heart of our response. The result was a vaccine that was developed in under a year, and we believe we have made a significant impact in terms of global public health. Based on data published in The Lancet and an analysis by Airfinity, our vaccine is estimated to have saved over 6 million lives in the first year of vaccination.

AstraZeneca supplied the vaccine with no profit during the pandemic and we are supplying the vaccine with no profit in low-income countries today. To date, over 3 billion doses have been released for supply to more than 180 countries. AstraZeneca was the first and largest contributor in 2020 and 2021 to COVAX, with over 470 million doses. Doses that couldn’t have been released without the partnership with ProPharma. In our collaboration an estimated 500 million doses underwent thorough quality assessment to provide a vaccine made for the world.

Pythia Segers - Astra Zeneca

"We have had the pleasure of working with ProPharma on a global scale for several years assisting us with Medical Information Call Center and writing workflows. Their ability to adapt based on the client’s needs is very commendable. Also, we are fortunate to work with a very talented team of professionals who are always eager to work with us and deliver quality service to our customers."

Anonymous

News & Insights

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

July 22, 2025

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

Discover how pharma marketers can build effective, compliant omnichannel marketing strategies to drive engagement and meet regulatory requirements.

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device Lifecycle Management

July 21, 2025

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device Lifecycle Management

Learn why relying solely on FMEA for medical device risk management falls short and how to adopt a more comprehensive approach to meet ISO 14971 standards.

CMC Expectations During Drug Substance Transfer from Ex-US Manufacturers

July 17, 2025

CMC Expectations During Drug Substance Transfer from Ex-US Manufacturers

Learn how to successfully transfer drug substance manufacturing to the U.S., with key CMC steps, comparability, validation, and FDA submission insights.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

July 22, 2025

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

Discover how pharma marketers can build effective, compliant omnichannel marketing strategies to drive engagement and meet regulatory requirements.

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device Lifecycle Management

July 21, 2025

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device Lifecycle Management

Learn why relying solely on FMEA for medical device risk management falls short and how to adopt a more comprehensive approach to meet ISO 14971 standards.

CMC Expectations During Drug Substance Transfer from Ex-US Manufacturers

July 17, 2025

CMC Expectations During Drug Substance Transfer from Ex-US Manufacturers

Learn how to successfully transfer drug substance manufacturing to the U.S., with key CMC steps, comparability, validation, and FDA submission insights.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow